Both in Orthopedic & Surgical Supplies
Edwards Lifesciences vs Enovis
Over the past year EW returned +14.9% and ENOV returned −33.7%; their daily moves had a correlation of 0.31.
EW +14.9% ENOV −33.7%Growth of $1, one year, split-adjusted
| Metric | EW | ENOV |
|---|---|---|
| Price | $95.48 | $20.82 |
| Market cap | $55.03B | $1.20B |
| Today | +2.38% | +0.97% |
| 1 month | +9.5% | +11.4% |
| 6 months | +15.2% | −13.7% |
| Year to date | +12.0% | −21.8% |
| 1 year | +15.8% | −33.4% |
| Revenue growth (YoY) | +13.6% | +3.2% |
| Gross margin | 77.5% | 61.6% |
| Net margin | 13.9% | −0.2% |
| P/E (TTM) | 54.8× | — |
| Price / sales | 8.5× | 0.5× |
| Net cash | $3.65B | -$1.27B |
| Dividend yield | — | — |
| Volatility (60d) | 23.5% | 65.0% |
| Short % of float | 1.6% | 20.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).